相关实验视频
Updated: Jul 26, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
在Kawasaki综合征后改变的脂质概况
J W Newburger1, J C Burns, A S Beiser
1Department of Cardiology, Children's Hospital, Boston, MA 02115.
Circulation
|August 1, 1991
概括
川崎综合征影响儿童的脂质水平,特别是长期降低高密度脂蛋白胆固醇. 持续监测对于管理这些患者心血管风险至关重要.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 脂质代谢 脂质代谢是什么
- 川崎疾病研究研究
背景情况:
- 川崎病 (KD) 影响儿童,并倾向于冠状动脉.
- 评估KD后的脂质概况对于长期的心血管健康至关重要.
- 了解脂质异常有助于预测和管理潜在的并发症.
研究的目的:
- 调查卡瓦萨基综合征后儿童的脂质代谢异常.
- 随着时间的推移跟踪总胆固醇,高密度胆固醇和甘油三的变化.
- 将KD患者的脂质水平与他们的父母进行比较,并评估与冠状动脉异常的相关性.
主要方法:
- 测量了血中总胆固醇,高密度胆固醇和甘油三的度.
- 在105名患有川崎综合征病史的患者中使用了酶方法.
- 在六个不同的时间间隔进行了测量,从急性阶段到病后3年多.
主要成果:
- 总胆固醇最初是压抑的,但在康复后恢复正常.
- 高密度脂蛋白 (HDL) 胆固醇仍然明显低于预期的长期,即使在最近的间隔.
- 甘油三水平最初很高,随着时间的推移而下降,尽管在统计学上没有显著意义.
- 与他们的父母相比,KD患者的总胆固醇类似,但HDL胆固醇显著降低.
- 在KD患者中,较低的HDL胆固醇水平趋向于持续的冠状动脉异常.
结论:
- 川崎综合征与脂质代谢中的显著,长期的异常有关.
- 异常的脂质特征,特别是降低的HDL胆固醇,在临床康复后持续很长时间.
- 在KD幸存者中,长期监测脂质水平对于监测心血管风险和动脉样硬化发展至关重要.
相关概念视频
Inflammation
Overview
Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
